Close Menu

NEW YORK – Natera reported after the close of the market on Wednesday that its second quarter revenues increased 18 percent, driven by sales of its Panorama noninvasive prenatal and Horizon carrier screening tests as well as a milestone and development payment by BGI.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.